Edwards Lifesciences Corp. (EW)

194.03
0.30 0.15
NYSE : Health Technology
Prev Close 194.33
Open 195.22
Day Low/High 194.09 / 196.75
52 Wk Low/High 134.53 / 197.86
Volume 1.00M
Avg Volume 1.27M
Exchange NYSE
Shares Outstanding 208.50M
Market Cap 40.26B
EPS 3.50
P/E Ratio 53.63
Div & Yield N.A. (N.A)

Latest News

Edwards Lifesciences To Host Earnings Conference Call On July 23, 2019

Edwards Lifesciences To Host Earnings Conference Call On July 23, 2019

IRVINE, Calif., July 9, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter...

IIROC Trading Resumption - EW

IIROC Trading Resumption - EW

VANCOUVER, June 25, 2019 /CNW/ - Trading resumes in: Company: East West Petroleum Corp.

IIROC Trading Halt - EW

IIROC Trading Halt - EW

VANCOUVER, June 24, 2019 /CNW/ - The following issues have been halted by IIROC: Company: East West Petroleum Corp.

Edwards Comments On Updated TAVR National Coverage Determination

Edwards Comments On Updated TAVR National Coverage Determination

IRVINE, Calif., June 21, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today commented on the final updated U.

Edwards Lifesciences To Present At The Goldman Sachs 40th Annual Global Healthcare Conference

Edwards Lifesciences To Present At The Goldman Sachs 40th Annual Global Healthcare Conference

IRVINE, Calif., June 4, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to present at the 40 th Annual Global...

Edwards Lifesciences Recommends Stockholders Reject "Mini-Tender Offer" By TRC Capital Corporation

Edwards Lifesciences Recommends Stockholders Reject "Mini-Tender Offer" By TRC Capital Corporation

IRVINE, Calif., June 3, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received notice of an...

Edwards Announces Milestones For Transcatheter Mitral Program

Edwards Announces Milestones For Transcatheter Mitral Program

PARIS, May 22, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regulatory milestones for its...

Favorable Study Outcomes Presented On Edwards Aortic Valves With RESILIA Tissue

Favorable Study Outcomes Presented On Edwards Aortic Valves With RESILIA Tissue

COMMENCE Trial Four-Year Data Presented at the AATS 99th Annual Meeting

Edwards Lifesciences To Webcast Annual Meeting Of Stockholders

Edwards Lifesciences To Webcast Annual Meeting Of Stockholders

IRVINE, Calif., May 1, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will host its Annual Meeting of Stockholders on Wednesday,...

Edwards Lifesciences Reports First Quarter Results

Edwards Lifesciences Reports First Quarter Results

IRVINE, Calif., April 23, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended...

These Stocks Are Too Hot: Cramer's 'Mad Money' Recap (Thursday 4/18/19)

These Stocks Are Too Hot: Cramer's 'Mad Money' Recap (Thursday 4/18/19)

Cramer says these red-hot and hopelessly overvalued IPOs are signs people are too bullish. Here's your game plan for next week.

Kraft Heinz, PepsiCo, Marvell Technology: 'Mad Money' Lightning Round

Kraft Heinz, PepsiCo, Marvell Technology: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Kraft Heinz, PepsiCo, Marvell Technology, General Mills, Funko, Signet Jewelers, Abiomed and more.

Edwards Lifesciences Completes Acquisition Of CASMED

Edwards Lifesciences Completes Acquisition Of CASMED

IRVINE, Calif., April 18, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced the completion of its acquisition of...

IIROC Trading Resumption - EW

IIROC Trading Resumption - EW

VANCOUVER, April 9, 2019 /CNW/ - Trading resumes in: Company: East West Petroleum Corp.

Edwards Lifesciences To Host Earnings Conference Call On April 23, 2019

Edwards Lifesciences To Host Earnings Conference Call On April 23, 2019

IRVINE, Calif., April 9, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter...

Markets Get a Lyft: Cramer's 'Mad Money' Recap (Friday 3/29/19)

Markets Get a Lyft: Cramer's 'Mad Money' Recap (Friday 3/29/19)

The biggest IPO of the year so far is likely to set a trend, Jim Cramer says.

Edwards Lifesciences Gains on Positive Heart Trial Results

Edwards Lifesciences Gains on Positive Heart Trial Results

The medical research and device company announces positive results from its recent aortic valve surgical treatment trial.

Edwards SAPIEN 3 Valve Proves Superior To Surgery In Partner 3 Trial

Edwards SAPIEN 3 Valve Proves Superior To Surgery In Partner 3 Trial

Results Published in the New England Journal of Medicine

New Relic, Edwards Lifesciences, Aphria: 'Mad Money' Lightning Round

New Relic, Edwards Lifesciences, Aphria: 'Mad Money' Lightning Round

Jim Cramer takes a look at New Relic, Edwards Lifesciences, Aphria, NovaGold Resources, Insperity and more.

Disrupt or Be Disrupted: Cramer's 'Mad Money' Recap (Wednesday 3/13/19)

Disrupt or Be Disrupted: Cramer's 'Mad Money' Recap (Wednesday 3/13/19)

Disruptors are among the biggest winners, says Jim Cramer. Companies like Apple and Kraft Heinz need to re-imagine their companies in bold, meaningful and even radical ways.

Edwards Lifesciences Announces Strategic Investments

Edwards Lifesciences Announces Strategic Investments

IRVINE, Calif., March 11, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced two strategic transactions involving...

Edwards PASCAL Transcatheter System Receives CE Mark

Edwards PASCAL Transcatheter System Receives CE Mark

IRVINE, Calif., Feb.

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition Of CAS Medical Systems, Inc.

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition Of CAS Medical Systems, Inc.

NEW YORK, Feb. 12, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against CAS Medical Systems, Inc.

Edwards Lifesciences Enters Into Agreement To Acquire CASMED

Edwards Lifesciences Enters Into Agreement To Acquire CASMED

IRVINE, Calif. and BRANFORD, Conn.

Edwards Lifesciences Reports Fourth Quarter Results

Edwards Lifesciences Reports Fourth Quarter Results

IRVINE, Calif., Jan.

Edwards Lifesciences' Stock Jumps on Patent Dispute Settlement

Edwards Lifesciences' Stock Jumps on Patent Dispute Settlement

Shares jump nearly 8% following agreement to pay rival Boston Scientific Corp. 4180 million to settle long-standing patent disputes.

TheStreet Quant Rating: B (Buy)